￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What should I do if resistance to ramucirumab develops? What to pay attention to

2025-10-19 11:44:20

Check Details
Just now! Lung cancer targeted drug Mobotinib is on the market! How much do you know about it?

2025-10-19 11:44:20

Check Details
How much does it cost to buy EGFR-MET bispecific antibody Rybrevant in Hubei? How to use?

2025-10-19 11:44:20

Check Details
How effective is the blockbuster new drug Rybrevant? Are there any serious side effects of Rybrevant?

2025-10-19 11:44:20

Check Details
The response rate of mobotinib, a drug targeting EGFR gene mutation in non-small cell lung cancer, reaches 43%_ Kanghule

2025-10-19 11:44:20

Check Details
Is Mobotinib on the market? Is there a place to sell it in Wuhan?

2025-10-19 11:44:20

Check Details
The anti-tumor drug Pozitinib has a lung cancer disease response rate of up to 90%

2025-10-19 11:44:20

Check Details
What conditions does larotrectinib mainly treat? Is the treatment effective

2025-10-19 11:44:20

Check Details
Will larotrectinib develop resistance? What should you pay attention to when using it

2025-10-19 11:44:20

Check Details
What drug is tepotinib? Is it effective?

2025-10-19 11:44:20

Check Details
【Drug Information】Take you into Tepotinib

2025-10-19 11:44:20

Check Details
LUMYKRAS receives positive opinion from CHMP for the treatment of patients with KRAS G12C mutated advanced NSCLC_ Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识